nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—Azoospermia—Cisplatin—bone cancer	0.0949	0.105	CcSEcCtD
Oxandrolone—Oligospermia—Methotrexate—bone cancer	0.0669	0.0739	CcSEcCtD
Oxandrolone—Oligospermia—Epirubicin—bone cancer	0.0627	0.0691	CcSEcCtD
Oxandrolone—Oligospermia—Doxorubicin—bone cancer	0.058	0.064	CcSEcCtD
Oxandrolone—Bronchial hyperreactivity—Methotrexate—bone cancer	0.0538	0.0593	CcSEcCtD
Oxandrolone—Azoospermia—Methotrexate—bone cancer	0.0521	0.0575	CcSEcCtD
Oxandrolone—Chronic obstructive pulmonary disease—Methotrexate—bone cancer	0.0491	0.0542	CcSEcCtD
Oxandrolone—Azoospermia—Epirubicin—bone cancer	0.0487	0.0538	CcSEcCtD
Oxandrolone—Azoospermia—Doxorubicin—bone cancer	0.0451	0.0498	CcSEcCtD
Oxandrolone—Necrosis—Cisplatin—bone cancer	0.0326	0.0359	CcSEcCtD
Oxandrolone—Fluid retention—Cisplatin—bone cancer	0.0243	0.0268	CcSEcCtD
Oxandrolone—Allylestrenol—CYP3A4—bone cancer	0.0186	0.347	CrCbGaD
Oxandrolone—Necrosis—Methotrexate—bone cancer	0.0179	0.0197	CcSEcCtD
Oxandrolone—Irritability—Cisplatin—bone cancer	0.0177	0.0195	CcSEcCtD
Oxandrolone—Blood creatinine increased—Cisplatin—bone cancer	0.0174	0.0192	CcSEcCtD
Oxandrolone—Necrosis—Epirubicin—bone cancer	0.0167	0.0185	CcSEcCtD
Oxandrolone—Necrosis—Doxorubicin—bone cancer	0.0155	0.0171	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Epirubicin—bone cancer	0.0149	0.0165	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Doxorubicin—bone cancer	0.0138	0.0153	CcSEcCtD
Oxandrolone—Creatinine increased—Epirubicin—bone cancer	0.0138	0.0152	CcSEcCtD
Oxandrolone—Creatinine increased—Doxorubicin—bone cancer	0.0128	0.0141	CcSEcCtD
Oxandrolone—Neoplasm—Methotrexate—bone cancer	0.0127	0.014	CcSEcCtD
Oxandrolone—Gynaecomastia—Methotrexate—bone cancer	0.0126	0.0139	CcSEcCtD
Oxandrolone—Fluid retention—Epirubicin—bone cancer	0.0125	0.0138	CcSEcCtD
Oxandrolone—Neoplasm—Epirubicin—bone cancer	0.0119	0.0131	CcSEcCtD
Oxandrolone—Fluid retention—Doxorubicin—bone cancer	0.0115	0.0127	CcSEcCtD
Oxandrolone—Neoplasm—Doxorubicin—bone cancer	0.011	0.0121	CcSEcCtD
Oxandrolone—Irritability—Methotrexate—bone cancer	0.00972	0.0107	CcSEcCtD
Oxandrolone—Danazol—CYP3A4—bone cancer	0.00934	0.174	CrCbGaD
Oxandrolone—Oedema—Cisplatin—bone cancer	0.00912	0.0101	CcSEcCtD
Oxandrolone—Blood creatinine increased—Epirubicin—bone cancer	0.00893	0.00985	CcSEcCtD
Oxandrolone—Norethindrone—CYP3A4—bone cancer	0.00831	0.155	CrCbGaD
Oxandrolone—Blood creatinine increased—Doxorubicin—bone cancer	0.00826	0.00912	CcSEcCtD
Oxandrolone—Erectile dysfunction—Methotrexate—bone cancer	0.00811	0.00895	CcSEcCtD
Oxandrolone—Methyltestosterone—CYP3A4—bone cancer	0.0079	0.147	CrCbGaD
Oxandrolone—Haemoglobin—Methotrexate—bone cancer	0.00708	0.00781	CcSEcCtD
Oxandrolone—Haemorrhage—Methotrexate—bone cancer	0.00705	0.00777	CcSEcCtD
Oxandrolone—Haemoglobin—Epirubicin—bone cancer	0.00663	0.00731	CcSEcCtD
Oxandrolone—Haemorrhage—Epirubicin—bone cancer	0.00659	0.00728	CcSEcCtD
Oxandrolone—Haemoglobin—Doxorubicin—bone cancer	0.00613	0.00677	CcSEcCtD
Oxandrolone—Haemorrhage—Doxorubicin—bone cancer	0.0061	0.00673	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—T—bone cancer	0.00553	0.137	CbGpPWpGaD
Oxandrolone—Progesterone—CYP3A4—bone cancer	0.00484	0.0904	CrCbGaD
Oxandrolone—Oedema—Epirubicin—bone cancer	0.00468	0.00517	CcSEcCtD
Oxandrolone—Testosterone—CYP3A4—bone cancer	0.00458	0.0855	CrCbGaD
Oxandrolone—Insomnia—Methotrexate—bone cancer	0.00453	0.005	CcSEcCtD
Oxandrolone—Oedema—Doxorubicin—bone cancer	0.00433	0.00478	CcSEcCtD
Oxandrolone—Insomnia—Epirubicin—bone cancer	0.00424	0.00468	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—NR1I2—bone cancer	0.00399	0.0992	CbGpPWpGaD
Oxandrolone—Insomnia—Doxorubicin—bone cancer	0.00392	0.00433	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—FEV—bone cancer	0.00381	0.0947	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00315	0.0784	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ZNF77—bone cancer	0.00161	0.04	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—RB1—bone cancer	0.00106	0.0264	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000909	0.0226	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—JUN—bone cancer	0.000829	0.0206	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000821	0.0204	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000793	0.0197	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000789	0.0196	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ZNF77—bone cancer	0.000775	0.0193	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000773	0.0192	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000763	0.019	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—JUN—bone cancer	0.000714	0.0177	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000704	0.0175	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000665	0.0165	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000661	0.0164	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000647	0.0161	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000641	0.0159	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RB1—bone cancer	0.000636	0.0158	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000632	0.0157	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR1I2—bone cancer	0.000545	0.0135	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—MDM2—bone cancer	0.000543	0.0135	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000536	0.0133	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.000514	0.0128	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000509	0.0126	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	0.0005	0.0124	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000479	0.0119	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—JUN—bone cancer	0.000472	0.0117	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000424	0.0105	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000417	0.0104	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000397	0.00987	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—FUS—bone cancer	0.000379	0.00941	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EGFR—bone cancer	0.000371	0.00922	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000355	0.00883	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000309	0.00768	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—JUN—bone cancer	0.000301	0.00748	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000295	0.00732	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000284	0.00706	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR1I2—bone cancer	0.000262	0.00652	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000256	0.00636	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000243	0.00604	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000204	0.00507	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000201	0.005	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF2S1—bone cancer	0.000194	0.00482	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000169	0.0042	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EZH2—bone cancer	0.000168	0.00418	CbGpPWpGaD
